Mantle cell lymphoma: open trials in Canada

9 open trials have a site in Canada. Registry data; only the trial team decides who can take part.

NCT06084936
A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma
Trial Treatment · Phase 3 · Hoffmann-La Roche
Victoria Hospital, London Health Sciences Centre, London · The Ottawa Hospital - General Campus, Ottawa · Princess Margaret Cancer Center, Toronto
Registry updated 2026-11-05
NCT07101328
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
Trial Treatment · Phase 1 · Eli Lilly and Company
Lady Davis Institute for Medical Research Jewish General Hospital, Montreal · University Health Network UHN Princess Margaret Cancer Centre, Toronto · BC Cancer - Vancouver, Vancouver
Registry updated 2026-11-04
NCT05365659
IKS03 in Patients With Advanced B Cell Non-Hodgkin Lymphomas
Trial Treatment · Phase 1 · Iksuda Therapeutics Ltd.
Jewish General Hospital, Montreal
Registry updated 2026-11-03
NCT06208735
CLIC-2201 for the Treatment of Relapsed/Refractory B Cell Malignancies
Trial Treatment · Phase 1 · British Columbia Cancer Agency
Alberta Children's Hospital, Calgary · Arthur J.E. Child Comprehensive Cancer Centre, Calgary · The Ottawa Hospital - General Campus, Ottawa · Princess Margaret Cancer Centre, Toronto · The Hospital for Sick Children, Toronto · BC Children ' s Hospital, Vancouver · Vancouver General Hospital, Vancouver
Registry updated 2026-10-14
NCT07341191
Sonrotoclax Plus Zanubrutinib in Patients With Relapsed/Refractory Mantle Cell Lymphoma Planned for Standard of Care CAR-T Cell Therapy
Trial Treatment · Phase 2 · Canadian Cancer Trials Group
Arthur J.E. Child Comprehensive Cancer Centre, Calgary · Cross Cancer Institute, Edmonton · Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton · University Health Network, Toronto · BCCA - Vancouver, Vancouver
Registry updated 2026-10-14
NCT05006716
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
Trial Treatment · Phase 1/2 · BeOne Medicines
Arthur Je Child Comprehensive Cancer Centre, Calgary · Cross Cancer Institute, Edmonton · Chu de Quebec Universite Laval, Hopital de Lenfant Jesus, Centre Integre de Cancerologie (Cic), Québec · Princess Margaret Cancer Centre, Toronto · British Columbia Cancer Agency the Vancouver Centre, Vancouver
Registry updated 2026-10-05
NCT06224309
Preliminary Assessment of [18F]BL40 in PET/CT Scans
Research · British Columbia Cancer Agency
BC Cancer, Vancouver
Registry updated 2026-10-01
NCT06542250
A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
Trial Treatment · Phase 1/2 · AstraZeneca
Calgary · Montreal · Toronto
Registry updated 2026-09-30
NCT04792489
DALY II USA/ MB-CART2019.1 for DLBCL
Trial Treatment · Phase 2 · Miltenyi Biomedicine GmbH
University of Alberta - Cross Cancer Institute, Edmonton · Princess Margaret Cancer Centre, Toronto
Registry updated 2026-07-13

All Mantle cell lymphoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error